SEARCH

SEARCH BY CITATION

References

  • 1
    Kannel W. The prognostic significance of proteinuria: the Framingham study. Am Heart J. 1984;108:13471352.
  • 2
    Keen H, Chlouverakis C. An immunoassay method for urinary albumin at low concentrations. Lancet. 1963;186:913914.
  • 3
    Keen H, Chlouverakis C. Urinary albumin excretion and diabetes mellitus. Lancet. 1964;14:11551156.
  • 4
    Viberti GC, Keen H. Microalbuminuria and diabetes. Lancet.1983;1:352.
  • 5
    American Dibetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26: S33S50.
  • 6
    Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999;33:10041010.
  • 7
    Eknoyan G, Hostetter T, Bakris GL, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation and the National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis. 2003;42:617622.
  • 8
    Viberti GC, Jarrett RJ, Keen H. Microalbuminuria as prediction of nephropathy in diabetics. Lancet. 1982;2:611.
  • 9
    Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356360.
  • 10
    Nelson RG, Meyer TW, Myers BD, et al. Clinical and pathological course of renal disease in non-insulin-dependent diabetes mellitus: the Pima Indian experience. Semin Nephrol. 1997;17:124131.
  • 11
    Nelson RG, Meyer TW, Myers BD, et al. Course of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Kidney Int Suppl. 1997;63:S45S48.
  • 12
    Jafar TH, Stark PC, Schmid CH, et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int. 2001;60:11311140.
  • 13
    Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int. 1997;51:215.
  • 14
    Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123:754762.
  • 15
    Eknoyan G, Hostetter T, Bakris GL, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis. 2003;42:617622.
  • 16
    Stehouwer CDA, Nauta JJ, Zeldenrust GC, et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 1992;340:319323.
  • 17
    Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997;157:14131418.
  • 18
    Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421426.
  • 19
    Jones CA, Francis ME, Eberhardt MS, et al. Micro-albuminuria in the US population: third national health and nutrition examination survey. Am J Kidney Dis. 2002;39:445459.
  • 20
    Gall MA, Borch-Johnsen K, Hougaard P, et al. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995;44:13031309.
  • 21
    Borch-Johnsen K. Incidence of nephropathy in IDDM as related to mortality. Costs and benefits of early intervention. In: MogensenCE, ed. The Kidney and Hypertension in Diabetes Mellitus. Boston , MA : Kluwer Academic Publishers; 2001:169178.
  • 22
    Allen KV, Walker JD. Microalbuminuria and mortality in long-duration type 1 diabetes. Diabetes Care. 2003;26:23892391.
  • 23
    Tuttle KR, Puhlman ME, Cooney SK, et al. Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study. Am J Kidney Dis. 1999;34:918925.
  • 24
    Jarrett RJ, Viberti GC, Argyropoulos A, et al. Micro-albuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med. 1984;1:1719.
  • 25
    Morgensen CE, Damsgaard EM, Froland A, et al. Microalbuminuria in non-insulin-dependent diabetes. Clin Nephrol. 1992;38:528538.
  • 26
    Mattock MB, Barnes DJ, Viberti G, et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes. 1998;47:17861792.
  • 27
    Damsgaard EM, Froland S, Jorgensen OD, et al. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297300.
  • 28
    Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412419.
  • 29
    Rossing P, Hougaard P, Borch-Johnsen K, et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ. 1996;313:779784.
  • 30
    Agewall S, Wikstrand J, Ljungman S, et al. Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Am J Hypertens. 1995;8:337342.
  • 31
    Agewall S, Wikstrand J, Ljungman S, et al. Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus. J Hypertens. 1995;13:463469.
  • 32
    Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, et al. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia. 1987;30:144148.
  • 33
    Jensen JS, Feldt-Rasmussen B, Strandgaard S, et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35:898903.
  • 34
    The Hope Trial Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355:253259.
  • 35
    Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145153.
  • 36
    Wachtell K, Ibsen H, Olsen MH, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139:901906.
  • 37
    Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997;157:14131418.
  • 38
    The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:25602572.